Zhongjun Luo
1PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
Pageof 1
Frequent Collaborators
1 joint publications
Melanie Royce
1 joint publications
Mirat Shah
1 joint publications
Lijun Zhang
1 joint publications
Joyce Cheng
1 joint publications
Mary Kate Bonner
1 joint publications
Melissa Pegues
1 joint publications
Claudia P Miller
1 joint publications
Lily Leu
1 joint publications
Lauren S L Price
1 joint publications
Junshan Qiu
